-
EP1161952
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1161952
| EP1161952 - Human therapeutic uses of BPI protein products [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.12.2007 Database last updated on 29.06.2024 | Most recent event Tooltip | 22.08.2008 | Change - representative | published on 24.09.2008 [2008/39] | Applicant(s) | For all designated states XOMA Technology Ltd. c/o XOMA (US) LLC, 2910 Seventh Street Berkeley, CA 94710 / US | [2001/50] | Inventor(s) | 01 /
Friedmann, Nadav 91 Bacon Court Lafayette, CA 94549 / US | 02 /
Van Deventer, Sander J.H. Meibergdreef 9 1105 AZ Amsterdam / NL | 03 /
Wedel, Nancy 5800 Ayala Avenue Oakland, CA 94609 / US | 04 /
Scannon, Patrick J. 176 Edgewood Avenue San Francisco, CA 94117 / US | 05 /
Von der Mohlen, Marijke A. M. George Sand straat 15 1105 AG Amsterdam / NL | [2002/19] |
| Former [2001/50] | 01 /
Friedmann, Nadav 91 Bacon Court Lafayette, CA 94549 / US | ||
| 02 /
Van Deventer, Sander J.H. Meibergdreef 9 1105 AZ, Amsterdam / NL | |||
| 03 /
Wedel, Nancy 5800 Ayala Avenue Oakland, CA 94609 / US | |||
| 04 /
Scannon, Patrick J. 176 Edgewood Avenue San Francisco, CA 94117 / US | |||
| 05 /
Von der Mohlen, Marijke A. M. Meibergdreef 9 1105 AZ, Amsterdam / NL | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2008/39] | Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | ||
| Former [2007/18] | Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3 80335 München / DE | ||
| Former [2001/50] | Richardson, Kate Forrester & Boehmert, Pettenkoferstrasse 20-22 80336 München / DE | Application number, filing date | 01121005.1 | 24.01.1995 | [2001/50] | Priority number, date | US19940188221 | 24.01.1994 Original published format: US 188221 | US19940291112 | 16.08.1994 Original published format: US 291112 | [2001/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1161952 | Date: | 12.12.2001 | Language: | EN | [2001/50] | Type: | A3 Search report | No.: | EP1161952 | Date: | 02.01.2002 | [2002/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.11.2001 | Classification | IPC: | A61K38/17, A61P31/00 | [2001/50] | CPC: |
C07K14/4742 (EP,US);
A61K38/1751 (EP,US);
A61P31/00 (EP);
A61P31/04 (EP);
A61P37/00 (EP);
A61P39/02 (EP);
| C-Set: |
A61K38/1751, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/50] | Title | German: | Therapeutische Verwendung der BPI Protein-Produkten | [2001/50] | English: | Human therapeutic uses of BPI protein products | [2001/50] | French: | Utilisation thérapeutique des produits contenant la protéine BPI | [2001/50] | Examination procedure | 03.06.2002 | Examination requested [2002/32] | 14.12.2006 | Despatch of a communication from the examining division (Time limit: M06) | 26.06.2007 | Application deemed to be withdrawn, date of legal effect [2008/02] | 20.08.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/02] | Parent application(s) Tooltip | EP95908723.0 / EP0741575 | Fees paid | Renewal fee | 31.08.2001 | Renewal fee patent year 03 | 31.08.2001 | Renewal fee patent year 04 | 31.08.2001 | Renewal fee patent year 05 | 31.08.2001 | Renewal fee patent year 06 | 31.08.2001 | Renewal fee patent year 07 | 12.04.2002 | Renewal fee patent year 08 | 14.01.2003 | Renewal fee patent year 09 | 14.01.2004 | Renewal fee patent year 10 | 12.01.2005 | Renewal fee patent year 11 | 25.01.2006 | Renewal fee patent year 12 | 12.01.2007 | Renewal fee patent year 13 | Penalty fee | Additional fee for renewal fee | 31.01.2002 | 08 M06 Fee paid on 12.04.2002 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO8901486 (UNIV NEW YORK [US]) [A] 1-20* the whole document *; | [X]WO9009183 (INVITRON CORP [US]) [X] 1-20 * the whole document *; | [X]WO9209621 (UNIV NEW YORK [US]) [X] 1-20 * claim 10 *; | [E]WO9510297 (XOMA CORP [US]) [E] 1,3,11,13 * the whole document *; | [X] - MARRA, M. ET AL, "The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin", JOURNAL OF IMMUNOLOGY, BALTIMORE US, vol. 148, no. 2, pages 532 - 537, XP002179296 [X] 1-20 * the whole document * | [X] - KHON, F. R. ET AL, "Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia", THE JOURNAL OF INFECTIOUS DISEASES, CHICAGO, vol. 168, no. 5, pages 1307 - 1310, XP002179297 [X] 1-20 * the whole document * | [X] - AMMONS, W.S. ET AL, "Recombinant amino terminal fragment of Bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin", CIRCULATORY SHOCK, NEW YORK, vol. 41, no. 3, pages 176 - 184, XP002179298 [X] 1-20 * the whole document * | [X] - MESZAROS, K. ET AL, "A recombinant amino terminal fragment of bactericidal/permeability increasing protein inhibits the induction of leukocyte responses by LPS", JOURNAL OF LEUKOCYTE BIOLOGY, NEW YORK, vol. 54, no. 6, pages 558 - 563, XP002179299 [X] 1-20 * the whole document * | [X] - MARRA, M.N. ET AL, "Bactericidal/permeability increasing protein has endotoxin-neutralising activity", JOURNAL OF IMMUNOLOGY, BALTIMORE US, vol. 144, no. 2, pages 662 - 666, XP002179300 [X] 1-20 * the whole document * | [X] - BARRON, R.L., "Pathophysiology of septic shock and implications for therapy", CLINICAL PHARMACY, BETHESDA MD, vol. 12, no. 111, pages 829 - 845, XP002179301 [X] 1-20 * the whole document * | [XP] - MAM VON DER MOHLEN ET AL, "Effect of rBPI23 on endotoxin-induced cytokine release and leukocyte changes in human volunteers", CLINICAL RESEARCH, THOROFARE N.J., vol. 42, no. 2, page 152A, XP002179302 [XP] 1-20 * the whole document * |